Today: 19 May 2026
Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM
4 February 2026
2 mins read

Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM

London, Feb 4, 2026, 09:17 GMT — Regular session

Sage Group plc (SGE.L) shares dropped 3.9% to 837 pence by mid-morning in London on Wednesday, deepening a steep selloff that’s hit software and data stocks hard this week.

The recent decline is significant as investors debate if AI automation might cut into subscription software’s paying users — and the reliable cashflows that underpin valuations.

Traders flagged Anthropic’s rollout of plug-ins for its Claude Cowork agent, designed to automate tasks in legal, sales, marketing, and data analysis. “Sometimes the market just shoots first and asks questions later,” said Mike Archibald, portfolio manager at AGF Investments. On Tuesday in London, Sage and rivals like Experian, London Stock Exchange Group, and Pearson dropped between 6% and 12%, Reuters reported. Reuters

Sage, better known for its accounting, payroll, and HR software, pushed back against that narrative in its latest update. On Jan. 27, the company reported a 10% rise in organic revenue—excluding acquisitions and currency effects—bringing it to £674 million. CFO Jacqui Cartin said Sage had “delivered a strong start to FY26” and reiterated full-year guidance. Sage

The company also highlighted additional AI capabilities in its product updates. “Decisions need to be made faster and with better information,” said Rob Sinfield, Sage’s SVP for ERP, as the firm unveiled new AI-driven enhancements to Sage X3, its ERP software aimed at mid-sized businesses. Sage

Not all broker opinions were bearish. On Monday, Canaccord Genuity bumped Sage up from “hold” to “buy,” lifting its price target to 1,135 pence. The firm called the recent selloff excessive, highlighting a 6% free cash flow yield and suggesting buybacks could tack on another 3-4% annual growth in earnings per share. London South East

Sage continues its stock buyback efforts. A recent filing revealed it purchased 1,964,614 shares on Feb. 3, paying a volume-weighted average price of 916.77 pence. The company confirmed these shares will be cancelled, part of its ongoing buyback programme.

The broader London market held steady, with the FTSE 100 gaining roughly 0.5% in early trading. Yet, Sage lagged behind despite the stronger index.

Yet, the swings might not head in a single direction. Nvidia CEO Jensen Huang dismissed the notion that AI will render software tools obsolete as “the most illogical thing in the world,” despite a selloff in software stocks extending into Asia on Wednesday. Reuters

Focus shifts to Sage’s annual general meeting on Thursday, Feb. 5, held at its Cobalt Park headquarters in Newcastle upon Tyne. Investors are set to challenge management on AI strategy, pricing policies, and capital returns.

The shareholder vote is also crucial for cash returns. Sage has put forward a 14.40 pence final dividend, set to be paid on Feb. 10 if the AGM approves it, to those on the register as of Jan. 9.

Following the AGM, the next key date is May 21, when the first-half interim results are due. This will give management a fresh opportunity to quantify how AI investments and new product launches are driving growth.

Stock Market Today

  • NASDAQ Futures Lead Declines Amid Tech Sector Pressure
    May 19, 2026, 5:27 AM EDT. Stock index futures fell Tuesday, with Nasdaq 100 futures dropping 0.39% to 28,882.59, leading declines as tech stocks remain under pressure. S&P 500 futures slipped 0.07% to 7,397.95, while Dow futures edged down 0.03% to 49,671.39. The moves reflect ongoing uncertainty in the tech sector, influencing investor sentiment across major U.S. indices. This comes as U.S. political developments continue to add to market cautiousness.

Latest articles

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

19 May 2026
GeoVax Labs shares surged nearly 80% to $2.21 Monday after announcing a $3 million private placement amid heightened interest in biodefense following a WHO emergency alert over Ebola in Africa. The company does not sell an approved Ebola vaccine; its lead candidate targets mpox and smallpox. GeoVax reported $1.3 million in cash at March 31 and a quarterly net loss of $5.3 million. The new funding is expected to close around May 19.
Evolution stock jumps on €2 billion move

Evolution stock jumps on €2 billion move

19 May 2026
Evolution AB shares surged 9% in Stockholm after the company announced a €2 billion share buyback, one of Sweden’s largest. The buyback starts immediately and may run until the 2027 annual meeting, capped at 10% of shares. The OMXS30 index rose just 0.75% in comparison. Evolution also secured a €300 million revolving credit facility from J.P. Morgan SE and Citibank Europe.
NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

19 May 2026
NextEra Energy shares fell 4.6% to $89.04 late Monday after announcing a $66.8 billion stock-led merger with Dominion Energy, whose shares rose 9.4% to $67.56. The deal would create one of the world’s largest electric utilities, serving about 10 million customer accounts and owning 110 gigawatts of generation across four states.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
BHP stock jumps nearly 5% as miners snap back — what investors watch before Feb. 17 results
Previous Story

BHP stock jumps nearly 5% as miners snap back — what investors watch before Feb. 17 results

SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion
Next Story

SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion

Go toTop